About NXT-Dx
NXT-Dx is a Healthcare company based in Gentbrugge (Belgium) founded in 2011 by Maarten Braspenning, and was acquired by Diagenode in August 2018. Epigenetics services are offered to life science researchers. The company was acqui-hired. Its focus areas include Life Sciences, Genomics, Genomics Services and Bioinformatics.
Company details
NXT-Dx was founded in 2011 and is based in Gentbrugge, Belgium. Services in epigenetics are provided to the life science community, including Infinium Methylation EPIC array, MBD-sequencing, MeDIP-seq, Reduced Representation Bisulfite Sequencing, and bisulfite sequencing variants for targeted, genome-wide, or whole-genome analysis. Additional offerings encompass genomics, transcriptomics, metagenomics, and bioinformatics support. Operations focus on advancing epigenetic and related genomic studies.
- Headquarters Gentbrugge, Belgium
- Founders Maarten Braspenning
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website nxt-dx.com
- Social LinkedIn X Facebook
- Acquired by Diagenode (Aug 2018)
Investors in NXT-Dx
NXT-Dx has secured backing from 1 investor. Prominent investors backing the company include Diagenode.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Reagents and kits for epigenetics sequencing solutions are developed. | 2003 | diagenode.com | Seraing, Belgium |
Investor details for NXT-Dx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NXT-Dx
1 people are tracked at NXT-Dx (1 in leadership).
| Name | Role | Group |
|---|---|---|
Maarten Braspenning | Co-Founder | Leadership |
Complete people profiles for NXT-Dx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of NXT-Dx
2 dated milestones of NXT-Dx across 7 years, from founding to its latest funding, stage changes and deals.
- Founded NXT-Dx is founded.
- Exit Acquired by Diagenode.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NXT-Dx
NXT-Dx was founded in 2011.
NXT-Dx is headquartered in Gentbrugge, Belgium. It is registered at Gentbrugge, East Flanders, Belgium.
NXT-Dx was founded in 2011 and is based in Gentbrugge, Belgium. Services in epigenetics are provided to the life science community, including Infinium Methylation EPIC array, MBD-sequencing, MeDIP-seq, Reduced Representation Bisulfite Sequencing, and bisulfite sequencing variants for targeted, genome-wide, or whole-genome analysis. Additional offerings encompass genomics, transcriptomics, metagenomics, and bioinformatics support. Operations focus on advancing epigenetic and related genomic studies.
NXT-Dx has 1 investor. Key investors include Diagenode.
Yes. NXT-Dx was acquired by Diagenode in August 2018.